Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development

Positive

AI Analysis

Summary

Actinium Pharmaceuticals appointed Sean Maenpaa, a radiopharmaceutical industry veteran with prior roles at Bayer, Clovis Oncology, Telix Pharmaceuticals and BWXT Medical, as Senior Vice President of Business Development. He will lead partnering, licensing and strategic transactions.

Outcome Details

Appointment of Sean Maenpaa as Senior Vice President, Business Development

Importance:5/10

Sentiment:

0.30

management changeexecutive appointmentbusiness developmentradiopharmaceuticaloncology

Related Companies

$BAYRY $CLVS $TLPPF

Read the original article

Published by PR Newswire Clinical Trials on October 16, 2026 11:30 AM

Read Original